Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 13,414 | 2,668 | 10,919 | 10,570 | 10,575 |
| Cost of Goods | 4,031 | 967 | 2,354 | 2,407 | 3,824 |
| Gross Profit | 9,383 | 1,701 | 8,565 | 8,163 | 6,751 |
| Operating Expenses | 23,239 | 26,007 | 28,231 | 35,959 | 38,204 |
| Operating Income | -13,825 | -23,339 | -19,312 | -27,389 | -30,629 |
| Interest Expense | 4,794 | 4,732 | 4,731 | 4,866 | 4,779 |
| Other Income | 23,020 | -23,508 | 11,448 | -4,501 | 1,949 |
| Pre-tax Income | 4,401 | -51,579 | -12,595 | -36,756 | -33,459 |
| Net Income Continuous | 4,401 | -51,579 | -12,595 | -36,756 | -33,459 |
| Net Income | $4,401 | $-51,579 | $-12,595 | $-36,756 | $-33,459 |
| EPS Basic Total Ops | 0.04 | -0.53 | -0.15 | -0.39 | -0.49 |
| EPS Basic Continuous Ops | 0.04 | -0.53 | -0.15 | -0.40 | -0.45 |
| EPS Diluted Total Ops | -0.15 | -0.53 | -0.25 | -0.39 | -0.49 |
| EPS Diluted Continuous Ops | 0.04 | -0.53 | -0.15 | -0.40 | -0.45 |
| EBITDA(a) | $-11,806 | $-21,452 | $-15,453 | $-23,502 | $-23,385 |